Related references
Note: Only part of the references are listed.A new, highly selective murine peroxisome proliferator-activated receptor δ agonist increases responsiveness to thermogenic stimuli and glucose uptake in skeletal muscle in obese mice
R. A. Ngala et al.
DIABETES OBESITY & METABOLISM (2011)
Therapeutic Trials in Nonalcoholic Steatohepatitis: Insulin Sensitizers and Related Methodological Issues
Vlad Ratziu et al.
HEPATOLOGY (2010)
Peroxisome proliferator-activated receptor δ agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis
Saravanan Kanakasabai et al.
IMMUNOLOGY (2010)
Identification and Characterization of 4-Chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a Selective and Irreversible Peroxisome Proliferator-Activated Receptor δ (PPARδ) Antagonist
Barry G. Shearer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
15-Hydroxyeicosatetraenoic Acid Is a Preferential Peroxisome Proliferator-Activated Receptor β/δ Agonist
Simone Naruhn et al.
MOLECULAR PHARMACOLOGY (2010)
Cellular and Pharmacological Selectivity of the Peroxisome Proliferator-Activated Receptor-beta/delta Antagonist GSK3787
Prajakta S. Palkar et al.
MOLECULAR PHARMACOLOGY (2010)
Activation of PPARβ/δ Causes a Psoriasis-Like Skin Disease In Vivo
Malgorzata Romanowska et al.
PLOS ONE (2010)
Different Effects of Thiazolidinediones on Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus: Pioglitazone vs Rosiglitazone
Rafael Simo et al.
CURRENT DRUG SAFETY (2010)
Sorting out the functional role(s) of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in cell proliferation and cancer
Jeffrey M. Peters et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2009)
A novel peroxisome proliferator-activated receptor delta antagonist, SR13904, has anti-proliferative activity in human cancer cells
Nurulain T. Zaveri et al.
CANCER BIOLOGY & THERAPY (2009)
Ligand activation of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) inhibits chemically induced skin tumorigenesis
Moses T. Bility et al.
CARCINOGENESIS (2008)
Adipocyte-derived Th2 cytokines and myeloid PPARδ regulate macrophage polarization and insulin sensitivity
Kihwa Kang et al.
CELL METABOLISM (2008)
Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance
Justin I. Odegaard et al.
CELL METABOLISM (2008)
PPAR delta enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGF-like growth factor
Malgorzata Romanowska et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Identification and characterization of a selective peroxisome proliferator-activated receptor β/δ (NR1C2) antagonist
Barry G. Shearer et al.
MOLECULAR ENDOCRINOLOGY (2008)
Ligand-Mediated Regulation of Peroxisome Proliferator-Activated Receptor (PPAR) β/δ: A Comparative Analysis of PPAR-Selective Agonists and All-trans Retinoic Acid
Markus Rieck et al.
MOLECULAR PHARMACOLOGY (2008)
Deregulation of tumor angiogenesis and blockade of tumor growth in PPARβ-deficient mice
Sabine Mueller-Bruesselbach et al.
EMBO JOURNAL (2007)
Peroxisome proliferator-activated receptor structures: Ligand specificity, molecular switch and interactions with regulators
Vincent Zoete et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Transcription coactivators for peroxisome proliferator-activated receptors
Songtao Yu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Transcriptional network governing the angiogenic, switch in human pancreatic cancer
Amir Abdollahi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Existing and potential therapeutic approaches targeting peroxisome proliferator-activated receptors in the management of Type 2 diabetes
Adam Stefanski et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2006)
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors
Liliane Michalik et al.
PHARMACOLOGICAL REVIEWS (2006)
International Union of Pharmacology. LXIII. Retinoid X receptors
Pierre Germain et al.
PHARMACOLOGICAL REVIEWS (2006)
PPARβ/δ regulates Paneth cell differentiation via controlling the hedgehog signaling pathway
Frederic Varnat et al.
GASTROENTEROLOGY (2006)
The nuclear receptor superfamily and drug discovery
John T. Moore et al.
CHEMMEDCHEM (2006)
Transcriptional regulation of metabolism
B Desvergne et al.
PHYSIOLOGICAL REVIEWS (2006)
Induction of PPAR beta and prostacyclin (PGI(2)) synthesis by Raf signaling: failure of PGI(2) to activate PPAR beta
T Fauti et al.
FEBS JOURNAL (2006)
The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation
AD Burdick et al.
CELLULAR SIGNALLING (2006)
Peroxisome proliferator-activated receptor β/δ as a therapeutic target for metabolic diseases
E Bedu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-δ accelerates intestinal adenoma growth
RA Gupta et al.
NATURE MEDICINE (2004)
Peroxisome proliferator-activated receptor α target genes
S Mandard et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor δ
DZ Wang et al.
CANCER CELL (2004)
Principles for modulation of the nuclear receptor superfamily
H Gronemeyer et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Peroxisome proliferator-activated receptor β (δ)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis
DJ Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Chimeric transcriptional control units for improved liver-specific transgene expression
S Gehrke et al.
GENE (2003)
Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ) -: Synthesis and biological activity
ML Sznaidman et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity
YX Wang et al.
CELL (2003)
Antiapoptotic role of PPARβ in keratinocytes via transcriptional control of the Akt1 signaling pathway
N Di-Poï et al.
MOLECULAR CELL (2002)
Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer
Y Barak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Glitazones: clinical effects and molecular mechanisms
M Stumvoll et al.
ANNALS OF MEDICINE (2002)
Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)α and PPARβ mutant mice
L Michalik et al.
JOURNAL OF CELL BIOLOGY (2001)
The PPARs: From orphan receptors to drug discovery
TM Willson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
